Immunological markers in multiple sclerosis

M. Gironi, A. Bergami, E. Brambilla, F. Ruffini, R. Furlan, G. Comi, G. Martino

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is characterized by the presence in the central nervous system (CNS) of perivascular inflammatory infiltrates containing, among others, autoreactive T cells and activated macrophages. These observations indicate that MS is a T cell-mediated CNS-confined chronic inflammatory demyelinating disease in which the ultimate effector cell is the activated macrophage. The inflammatory process, leading to patchy demyelination and axonal loss, is mainly sustained by pro-inflammatory cytokines that, along with chemokines, adhesion molecules and metalloproteases, modulate at different levels the pathogenic process underlying MS. Due to their central role in MS pathogenesis, "inflammatory" molecules might represent suitable peripheral markers of disease (disease-trait) and/or disease activity (state-trait). However, reliable disease-trait or state-trait immunological markers for MS have not yet been identified. The intrinsic characteristics of these molecules (i.e. autocrine/paracrine activity, short half-life, redundancy) may in part explain their inconsistency as disease markers. Additionally, the unreliability of methodologies and the lack of careful patient stratification can also, at least in part, account for the unsatisfactory results so far obtained.

Original languageEnglish
JournalNeurological Sciences
Volume21
Issue number8
Publication statusPublished - 2000

Fingerprint

Multiple Sclerosis
Demyelinating Diseases
Central Nervous System
Macrophages
T-Lymphocytes
Metalloproteases
Chemokines
Half-Life
Cytokines

Keywords

  • Adhesion molecules
  • Chemokines
  • Cytokines
  • Disease-trait markers
  • Metalloproteases
  • State-trait markers

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Gironi, M., Bergami, A., Brambilla, E., Ruffini, F., Furlan, R., Comi, G., & Martino, G. (2000). Immunological markers in multiple sclerosis. Neurological Sciences, 21(8).

Immunological markers in multiple sclerosis. / Gironi, M.; Bergami, A.; Brambilla, E.; Ruffini, F.; Furlan, R.; Comi, G.; Martino, G.

In: Neurological Sciences, Vol. 21, No. 8, 2000.

Research output: Contribution to journalArticle

Gironi, M, Bergami, A, Brambilla, E, Ruffini, F, Furlan, R, Comi, G & Martino, G 2000, 'Immunological markers in multiple sclerosis', Neurological Sciences, vol. 21, no. 8.
Gironi M, Bergami A, Brambilla E, Ruffini F, Furlan R, Comi G et al. Immunological markers in multiple sclerosis. Neurological Sciences. 2000;21(8).
Gironi, M. ; Bergami, A. ; Brambilla, E. ; Ruffini, F. ; Furlan, R. ; Comi, G. ; Martino, G. / Immunological markers in multiple sclerosis. In: Neurological Sciences. 2000 ; Vol. 21, No. 8.
@article{7a41a4dbfa1147bb9cb774d8197deaac,
title = "Immunological markers in multiple sclerosis",
abstract = "Multiple sclerosis (MS) is characterized by the presence in the central nervous system (CNS) of perivascular inflammatory infiltrates containing, among others, autoreactive T cells and activated macrophages. These observations indicate that MS is a T cell-mediated CNS-confined chronic inflammatory demyelinating disease in which the ultimate effector cell is the activated macrophage. The inflammatory process, leading to patchy demyelination and axonal loss, is mainly sustained by pro-inflammatory cytokines that, along with chemokines, adhesion molecules and metalloproteases, modulate at different levels the pathogenic process underlying MS. Due to their central role in MS pathogenesis, {"}inflammatory{"} molecules might represent suitable peripheral markers of disease (disease-trait) and/or disease activity (state-trait). However, reliable disease-trait or state-trait immunological markers for MS have not yet been identified. The intrinsic characteristics of these molecules (i.e. autocrine/paracrine activity, short half-life, redundancy) may in part explain their inconsistency as disease markers. Additionally, the unreliability of methodologies and the lack of careful patient stratification can also, at least in part, account for the unsatisfactory results so far obtained.",
keywords = "Adhesion molecules, Chemokines, Cytokines, Disease-trait markers, Metalloproteases, State-trait markers",
author = "M. Gironi and A. Bergami and E. Brambilla and F. Ruffini and R. Furlan and G. Comi and G. Martino",
year = "2000",
language = "English",
volume = "21",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "8",

}

TY - JOUR

T1 - Immunological markers in multiple sclerosis

AU - Gironi, M.

AU - Bergami, A.

AU - Brambilla, E.

AU - Ruffini, F.

AU - Furlan, R.

AU - Comi, G.

AU - Martino, G.

PY - 2000

Y1 - 2000

N2 - Multiple sclerosis (MS) is characterized by the presence in the central nervous system (CNS) of perivascular inflammatory infiltrates containing, among others, autoreactive T cells and activated macrophages. These observations indicate that MS is a T cell-mediated CNS-confined chronic inflammatory demyelinating disease in which the ultimate effector cell is the activated macrophage. The inflammatory process, leading to patchy demyelination and axonal loss, is mainly sustained by pro-inflammatory cytokines that, along with chemokines, adhesion molecules and metalloproteases, modulate at different levels the pathogenic process underlying MS. Due to their central role in MS pathogenesis, "inflammatory" molecules might represent suitable peripheral markers of disease (disease-trait) and/or disease activity (state-trait). However, reliable disease-trait or state-trait immunological markers for MS have not yet been identified. The intrinsic characteristics of these molecules (i.e. autocrine/paracrine activity, short half-life, redundancy) may in part explain their inconsistency as disease markers. Additionally, the unreliability of methodologies and the lack of careful patient stratification can also, at least in part, account for the unsatisfactory results so far obtained.

AB - Multiple sclerosis (MS) is characterized by the presence in the central nervous system (CNS) of perivascular inflammatory infiltrates containing, among others, autoreactive T cells and activated macrophages. These observations indicate that MS is a T cell-mediated CNS-confined chronic inflammatory demyelinating disease in which the ultimate effector cell is the activated macrophage. The inflammatory process, leading to patchy demyelination and axonal loss, is mainly sustained by pro-inflammatory cytokines that, along with chemokines, adhesion molecules and metalloproteases, modulate at different levels the pathogenic process underlying MS. Due to their central role in MS pathogenesis, "inflammatory" molecules might represent suitable peripheral markers of disease (disease-trait) and/or disease activity (state-trait). However, reliable disease-trait or state-trait immunological markers for MS have not yet been identified. The intrinsic characteristics of these molecules (i.e. autocrine/paracrine activity, short half-life, redundancy) may in part explain their inconsistency as disease markers. Additionally, the unreliability of methodologies and the lack of careful patient stratification can also, at least in part, account for the unsatisfactory results so far obtained.

KW - Adhesion molecules

KW - Chemokines

KW - Cytokines

KW - Disease-trait markers

KW - Metalloproteases

KW - State-trait markers

UR - http://www.scopus.com/inward/record.url?scp=0034564726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034564726&partnerID=8YFLogxK

M3 - Article

C2 - 11205366

AN - SCOPUS:0034564726

VL - 21

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 8

ER -